Navega Therapeutics

Navega Therapeutics

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://navegatx.com

Last Round

Grant

Sep 25, 2025

Total Funding Raised

$8.93M

Momentum Score

50 /100

Company Overview

Navega Therapeutics is a biotechnology company developing non-permanent, epigenetic-regulation gene therapies to treat chronic pain and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, ML Platforms

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Application

Keywords

epigenetic gene therapychronic pain gene therapynon-addictive pain reliefopioid alternativeAI drug discoveryepigenetic editorsgene silencingNaV1.7 targetAAV gene therapyCRISPR therapyzinc finger proteinSCN9A gene repressiondCas9 systemneuropathic painsmall fiber neuropathy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Navega Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Navega Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantSep 25, 2025
GrantFeb 4, 2025
GrantJan 27, 2022
GrantSep 29, 2021
GrantSep 26, 2019
Grant
Sep 13, 2019

Key People

Founding team and executive leadership

Ana Maria Moreno

Founder, CEO

Founding Team

Navega Therapeutics Investors

Notable investors and investment history

Navega Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Navega Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Navega Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range9
Year Founded2018
Last FundingSep 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.